Explore the details of the Novartis Pharmaceuticals Corporation V. Cipla Limited case under case number 1:25-cv-00216 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:25-cv-00216
Filing Date
Feb 21, 2025
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Cipla Limited -
Novartis AG -

Patents Involved in the Case

There is a single patent involved in this case.

Application NumberPatent Number
-US8389537B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Feb 21, 2025Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis AG, Novartis Pharmaceuticals Corporation. (oam) (Entered: 02/24/2025)PACER Document
Feb 21, 2025Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,389,537. (oam) (Entered: 02/24/2025)PACER Document
Feb 21, 2025Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: N/A. Date of Expiration of Patent: See Attached. (oam) (Entered: 02/24/2025)PACER Document
Feb 21, 2025Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam) (Entered: 02/24/2025)PACER Document
Feb 21, 2025COMPLAINT against Cipla Limited and Cipla USA, Inc. (Filing fee $ 405, receipt number ADEDC-4620725) - filed by Novartis Pharmaceuticals Corporation, Novartis AG. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(oam) (Entered: 02/24/2025)PACER Document
Feb 21, 2025No Summons Issued. (oam)PACER Document
Feb 21, 2025COMPLAINT against Cipla Limited and Cipla USA, Inc. (Filing fee $ 405, receipt number ADEDC-4620725) - filed by Novartis Pharmaceuticals Corporation, Novartis AG. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(oam) (Entered: 02/24/2025)Attachment
Feb 21, 2025COMPLAINT against Cipla Limited and Cipla USA, Inc. (Filing fee $ 405, receipt number ADEDC-4620725) - filed by Novartis Pharmaceuticals Corporation, Novartis AG. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(oam) (Entered: 02/24/2025)Attachment